Drvota V
Karolinska Institute at Department of Cardiology, Huddinge University Hospital, Sweden.
Biochem Biophys Res Commun. 1998 Jan 26;242(3):593-6. doi: 10.1006/bbrc.1997.8013.
The thyroid hormone receptors (TR) and the retinoic acid receptors share a high degree of homology and their signaling pathways interplay. Thyroid hormone (T3) is known to be associated with various pathological heart conditions. Retinoids are known to ameliorate symptoms in hyperthyroid patients. The aim of this study was to investigate if retinoic acid (RA) can have any effects on TR in cardiac cells and thus play a role in heart disease. Confluent AT-1 cardiomyocytes were treated with RA, T3 depleted medium and DITPA (a cardiotonic T3 analogue) for 48 hours. Solution hybridization for the determination of mRNA for TR alpha 1, alpha 1, beta 1 and beta 2 was performed. RA, T3 and DITPA significantly downregulated the alpha 1, beta 1 and beta 2. The T3 depleted medium did not affect the TR subtypes. The specificity of the solution hybridization method was tested by an RNase protection assay. In conclusion, RA downregulates TR in a similar way as T3 in cardiac cells, indicating a role for RA in thyroid associated heart disease.
甲状腺激素受体(TR)与视黄酸受体具有高度同源性,且它们的信号通路相互作用。已知甲状腺激素(T3)与多种病理性心脏疾病相关。已知类视黄醇可改善甲状腺功能亢进患者的症状。本研究的目的是调查视黄酸(RA)是否会对心脏细胞中的TR产生任何影响,从而在心脏病中发挥作用。将汇合的AT - 1心肌细胞用RA、T3缺失培养基和DITPA(一种强心T3类似物)处理48小时。进行溶液杂交以测定TRα1、α1、β1和β2的mRNA。RA、T3和DITPA显著下调α1、β1和β2。T3缺失培养基不影响TR亚型。通过核糖核酸酶保护试验测试了溶液杂交方法的特异性。总之,RA在心脏细胞中以与T3类似的方式下调TR,表明RA在甲状腺相关心脏病中发挥作用。